Skip to main content
Image of syringe and pipets)

Therapeutic Areas and Products

Allergy and Immunology

Our world-leading immunoglobulin (Ig) franchise is the cornerstone of the immunology therapeutic area. Our efforts in this area focus on bringing trusted products and technologies to serve patients with a range of rare and serious diseases, including Primary Immunodeficiencies (PID) and Hereditary Angioedema (HAE).

Key Publications

Suppression of Rh Isoimmunization
Pharmacokinetics of anti-D IgG in pregnant RhD-negative women
Bichler, J et al
J Obstet Gynaecol 2003

Request | Ask a Question

Efficacy and safety of a new, chromatographically purified rhesus (D) immunoglobulin
MacKenzie, IZ et al
European Journal of Obstetrics & Gynecology and Reproductive Biology 2004
Request | Ask a Question

ITP
Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac®) in chronic immune thrombocytopenic purapura
Aledort LM et al
Hematology 2007

Request | Ask a Question

For U.S. Healthcare Professionals only

The purpose of this CSL Behring Medical Affairs website is to support Healthcare Professionals with scientific information. This website is also a channel for U.S. Healthcare Professionals to submit questions or connect with CSL Behring U.S. Healthcare Professionals. The information provided is for educational purposes only and is not intended to promote any products. By continuing to use this site you are acknowledging that you are a US Healthcare Professional